chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from an office manager and refers to an unspecified number of patients of unknown age and gender. The patient's medical history, concurrent conditions and allergies were not reported. On an unknown dates, the unspecified patients were vaccinated with dose of (Oka/Merck) VARIVAX, (lot # K005426 with expiration date: 15-APR-2016; and lot# reported as J011407 with expiration date: 13-NOV-2015 00), (strength, dose, frequency, route and anatomical location were not reported), which were improperly stored. Other suspect and concomitant therapies were not reported. No adverse events were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Our son started to lose awareness. He wouldn't respond to his name and stop giving eye contact. He start to have some language but lost all his language. He would blow kisses and interact, we lost all of that.
Acute exacerbation of back pain with radiation in L4 L5 dermatomes to knee. Numbness a large part of the symptomatology at times. Saw pain Physician suggested it was inflammation related to vaccine, Advil and steroids Improving but was debilitating and remain numb in that area with paraesthesia
Patient stopped breathing at 6:15pm on 04/22/2021. Fire dept was called. He went into cardiac arrest and they took him to ICU. He died on 04/26/2021 in ICU.
I HAD COVID-19 ON 11/15/2020-11/25/2020, RIGHT AFTER THE SHOT, THE ADMINISTERING NURSE SAID "PEOPLE WHO HAD THE VIRUS TEND TO HAVE WORSE REACTIONS (SIC)" SHE TOLD ME HOW IT MAY REACT. NEXT DAY, MY LEFT ARM HAD (2) PUNCTURE WOUNDS. IT FELT LIKE I WAS SLUGGED HARD AND ANY TOUCH HURT. TEMPERATURE 2 DEGREES ABOVE NORMAL.  FRIDAY 04/09/2021: CONDITION IMPROVE WITH ADDED MUCUS DISCHARGE. REDUCED MUCUS RELIEF. CONTINUE WITH OTHER OVER COUNTER AND PRESCRIBED MEDICINES. TEMP DROP BELOW 100 DEGREES. SO EXHAUSTED AND PHYSICALLY SORE. UNABLE TO PERFORM NORMAL DAILY FUNCTIONS FROM THE START OF THIS.  HOW LONG WILL THIS LAST? WHY ISN'T THE USE OF KNOWN TO HELP MSOS BEING PRESCRIBED, I.E. IVERMECTIN, HCQ, Z-PACK? WHY HASN'T THE POPULATION BEEN WARNED OF THIS REACTION, INCREASED POSSIBILITY, AHEAD OF INOCULATION? SHOULD THIS VACCINE BE EVEN OFFERED FOR PEOPLE WITH HEALTH CONDITIONS LIKE MYSELF, MY AGE GROUP, MY GEOGRAPHY, ETC., INSTEAD OF OTHER(S) LIKE JOHNSON & JOHNSON'S 1 SHOT; ESPECIALLY SINCE I ALREADY HAVE COVID-19 ANTIBODIES FROM BEFORE??  EACH DAY SINCE, I'VE GAINED SLOWLY. IT'S NOW 04/15/2021. THE ABILITY TO FULLY FUNCTION HAS NOT RETURNED. EACH DAY I'VE GAINED NOW UP TO 85% AND THEN I GET WEAK AND MUST REST. HOW LONG WILL THIS GO ON AM I NOW PERMANENTLY IMPACTED BY THIS?  TODAY'S DATE 04/29/2021 MUCUS DISCHARGE STILL DIFFERENT, YELLOWISH COLOR WITH LIGHT AMPUNTS. USUALLY AFTER EATING IT HITS ME LIKE A NASTY HACKING, SNEEZING, SNORTING, YUCK TO GET IT OUT OF ME.   BREATHING DEEP BETTER, BUT TIMES MORE DIFFICULT. INABILITY TO SING SONGS, WORSHIP GOD IN PRAISE IS BROKEN.  IS THIS PERMANENT? CAN I STILL GET THE VIRUS, OR ARE MY ANTIBODIES SO HIGH NOW THAT I'M IMMUNE? I'M SERIOUSLY AFRAID IF THIS HAPPENS AGAIN, I MAY NOT SURVIVE IT.   NOW 05/01/21 - DOCTOR APPT'S FOR MON. & TUES. 05/03-04/21. WILL DISCUSS W/ BOTH, TUES W/DR. WONDER IF LUNGS DAMAGE WILL STAY??
I threw up a few days after the vaccine. I had extreme body aches and swelling in my joints. I had a typical RA flare up. But it was to the point where I was not able to walk for a few days. My prednisone was increased and my activra was also increased. This helped. Along with this was extreme fatigue
pt w/exposure to varicella whose sibling was vax on 6/10/98 & 6/24 devel 30 vesicular small pox. 7/7 pt devel chickenpox approx 100 small vesicles & papules 28 days p/ brothers vax & 14 days p/ brothers rash. tests identified wild type.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Nurse states expired GARDASIL (lot # reported as 1397AA, Exp Date 09-APR-2013) (dose, route and indication were not reported) was administered to a patient. Concomitant medications were not reported. No adverse effects reported. The outcome of the patient was not reported. Additional information has been requested.
6/27/13 60 year old male. Pt walked into the ER. Pt states he received a zoster vaccine yesterday and today he developed an itchy rash all over his body, except face. No SHOB, lip, tongue or throat swelling, or other problems. 6/29/13 Pt presented day before yesterday with lower body rash. Was seen by ER physician (See ER Physician notes of 27th). Pt says that he is still itchy. He had couple of more lesions which appeared. No fever/chills or other symptoms. There is small round isolated widely spaced papular lesion, some with scab on them due to itching/bleeding. Distribution is mainly on legs. No cellulitis. Allergic rash to zoster vaccine-non injection site. D/C home. Increase BENADRYL to 50 mg po bid. C/E prednisone as prescribed before. PCP to follow. I have advised patient to seek further care immediately if the current condition and symptoms get worse or do not seem to get better or if any new symptom or problem develops. The patient voiced understanding and agreed.
Patient reported nausea, vomiting, and abdominal cramps one day after the vaccination. He went to a doctor. Patient reports that the doctor did not treat his cramping. Two days after the vaccination, patient came into the pharmacy reporting symptoms were much better, but he still reported small amounts of abdominal cramping.
COVID 19 Treatment; COVID 19 Treatment; Dose: 1, 2, 3. 4 Moderna/Dose 5 Pfizer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Sep2022 at 13:00 as dose 5 (booster), single (Lot number: GH9702) at the age of 68 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 15Feb2021 at 13:00 as dose 1, single (Lot number: 031L20A), in left arm, on 15Mar2021 at 13:00 as dose 2, single (Lot number: 045A21A), in right arm, on 15Nov2021 at 13:00 as dose 3 (booster), single (Lot number: 012F21A), in right arm and on 05May2022 at 13:00 as dose 4 (booster), single (Lot number: 045L21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Mechanical Aortic Valve" (unspecified if ongoing); "Aortic Aneurysm" (unspecified if ongoing). Concomitant medication(s) included: WARFARIN, start date: 09Jul1996; PANTOPRAZOLE, start date: 01Feb2018. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 21Sep2022 at 13:00, outcome "unknown", described as "Dose: 1, 2, 3. 4 Moderna/Dose 5 Pfizer"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Treatment was Paxlovid.
Myalgia soreness at injection site, malaise on day 2 after injection Narrative:
48 year old female with left shoulder pain x 2 days after getting 1st Moderna COVID vaccine 1 week ago in left deltoid. Pain is from deltoid to trapezius with significantly reduced active ROM. She felt really poorly about 6 hours after vaccine and missed work x 2 days. She felt better and resumed normal activities. On day 6 shoulder got really painful and unable to move normally. She denies redness or itching. No palpable lymphadenopathy but didn't go looking. No axillary pain.
Information has been received from a mother concerning her 16 year old daughter with no known drug allergies and asthma, who on 14-AUG-2007 was vaccinated with the first dose of GARDASIL vaccine (yeast) (Lot # not reported). On 17-OCT-2007, the patient was vaccinated with the second dose of GARDASIL vaccine (yeast) (Lot # not reported). On 27-FEB-2008, the patient received the third dose of GARDASIL vaccine (yeast) (Lot # not reported), 0.5 mL by injection. There was no concomitant therapy. The mother reported that on approximately 27-MAY-2008, three months after receiving the third dose of GARDASIL vaccine (yeast), her daughter experienced severe chronic diarrhea which had been occurring for the next two months. The patient sought medical attention. A colonoscopy, blood work, and stool sampling were performed (dates and results not reported). At the time of the report the patient had not recovered. Additional information has been requested. Follow up information was received from a physician which reported that the 16 year old patient received her first, second, and third dose of Gardasil into her left deltoid. The physician reported that in May 2008, the patient was diagnosed with Crohn's disease. At the time of the report the patient had not recovered. Additional information is expected.
Fever, headache, chill, lethargic and rash around area where injected.
Case was vaccinated and boosted against Covid, then was hospitalized for Covid.  Hospitalized at:   COVID-19 infection  Assessment & Plan - Still requiring supplemental oxygen, which is consistent with her new baseline since first COVID infection 10/2021 - Continue remdesivir until discharge, no need for ongoing treatment as an outpatient due to pt being asymptomatic - Lung exam normal, still deferring dexamethasone given mildness of illness, cognitive impairment, age, and known vertebral fracture
Started feeling a little bit bad like the blood had rushed to head; Started feeling a little bit bad like the blood had rushed to head; Wondering if a side effect; cheeks part on the bottom of jaw where teeth behind the gummies had little balls; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  A 79 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Mar2021 10:15 (Batch/Lot number: unknown) at the age of 79 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: FEELING ABNORMAL (non-serious), SENSATION OF BLOOD FLOW (non-serious) all with onset 05Mar2021, outcome "unknown" and all described as "Started feeling a little bit bad like the blood had rushed to head"; JAW DISORDER (non-serious) with onset 05Mar2021, outcome "unknown", described as "Wondering if a side effect; cheeks part on the bottom of jaw where teeth behind the gummies had little balls". Therapeutic measures were not taken as a result of feeling abnormal, sensation of blood flow, jaw disorder. Additional Information: The reporter went in the morning at 10:15am to get the COVID-19 vaccine for the patient (grandmother). The patient went to get the COVID Vaccine and waited there as she needed to and didn't have any reaction. However, when the patient came home, she started feeling a little bit bad like she felt like the blood had rushed to her head and then she went to sit down and she drink some water and rested for a bit and then she ate some food and then went to sleep. However, when she woke up on the parts where the cheeks part on the bottom of the jaw on the part where the teeth are like behind the gummies she felt like she had balls like little balls. They were concerned because they were wondering if that was a side effect of the Covid Vaccine. The reporter stated, "Yes, the balls were in her mouth like behind the cheeks where the gum is behind it that was about." The reporter stated they were not sure about all the name of her concomitant medications. There were no treatment for the problems.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This report describes the occurrence of gasping in a 5-month-old female who was vaccinated with diptheria and tetanus toxoids and aellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  This report was received from the subject's mother and has not been verified by a physician or other health care professional.  The subject's medical history reportedly included premature birth and reflux.  There were reportedly no adverse experiences following previous immunizations.  Concurrent medications included ranitidine (Zantac).  On 09/17/2002, the subject received her second injection of Infanrix into her right leg.  Approximately 7 hours post-immunization, the subject "started screaming uncontrollably, gasping for breath, face very white and eyelids red."  Approximately 8 hours post-immunization, the subject was taken to the emergency room.  Her pulse was reportedly "fine".  The infant was able to successfully feed, so she was sent home.  On 09/14/2002, approximately 5 hours after her emergency room visit, the subject developed a fever of 101.8 degrees Fahrenheit.  Her mother administered ibuprofen (Motrin).  Two hours later, the subject's temperature was 99.6 degrees Fahrenheit.  Subsequently, the subject "started kicking right leg were the injection was given."  The mother checked the injection site and found it to be "hot, hard, red, and enlarged to the size of a dime."  The subject was taken to an urgent care center, where the injection site swelling was reportedly noted to be the "size of a quarter."  The physician reportedly made a diagnosis of injection site infection and prescribed amoxicillin.  However, the subject's parents did not fill the prescribption.  Instead, the mother administered ibuprofen and paracetamol (Tylenol).  The mother reported that the gasping, uncontrolable screaming, fever, and injection site warmth resolved on 09/15/2002.  The injection site redness, induration, and swelling resolved on 09/18/2002.  The outcome of the pallor and eyelid redness were not specified.
Patient passed out in the chair immediately following vaccine. After she would not wake up a few minutes later 911 was called.   She still did not wake up once 911 was here. After they did a sternum run she woke, was crying historically, and unresponsive to their questions. She was put on the stretcher and went to the hospital
Arm swelled up, became inflamed and feverish, painful within several hours. Kept getting worse. Saw Dr on 10-2-13 and he said I had cellulitis. Prescribed antibiotic KEFLEX 10 days, ADVIL 3 x day, heat pad on arm. I had a very bad reaction within hours after my flu shot and want to be sure it is reported. The lady pharmacist who administered the shot was not there when I called and they said she would not be back until the following week. However, the pharmacist I talked with evidently gave her my name and phone number because she called me back almost immediately. She said she would call me back later because she needed more information for her report but she has not done so. I made a copy of the information from the Pharmacy which should be helpful to you. I filled out the form to the best of my ability. This is the first time I have had a violent reaction to a flu shot in about 30 years. I went many years without them after my children were grown. I resumed the shots when I was in my 50's because the Dr.'s office insisted I should get them because of my age. I was sick with one thing after another for 4 months after that 1st shot but never had another bad reaction until now. I'm 84 and I will not get another flu shot in the future.
5in x 6in erythema, swollen, warm to touch and tender area on back of L arm where Varicella was given at Pt. First 3 days ago. ZYRTEC given today, hydrocortisone cream 1 % applied and ice pack applied.
pt recv vax 12JUL96 & p/3rd dose of vax pt exp h/a, nausea,  & SOB;the event required a visit to the ER;the events are cont;further details have been requested;
Swelling, warmth, redness to left deltoid at injection site started 12/29/2020. Measures 3.5 inches vertical and 2 inches wide. Ice and advil.
Doses administered to 3 patients after temperature excursion; Temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered to 3 patients after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2022 at 8:40 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 07-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered to 3 patients after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered to 3 patients after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported.
The evening of receiving the vaccine, at around 10pm I started feeling pain in both my hands. It felt like I had baseball gloves on they were throbbing and very painful later that night I experienced that excruciating pain in all my joints. I couldn't stand up for a few days The excruciating pain went away but pain still remains. The pain lasted for 9 weeks. I also had vertigo I also had covid toes and fingers. I had blistering at the base of my nails and my toes were bright red. I also had rashes. They were little red pinprick like rashes on my arms and neck. I was also extremely fatigued. I contacted my primary care doctor on day 7. She said not to worry. I then contacted my acupuncturist. I then received acupuncture 2x a week along with a gentle movement program. The acupuncture helped temporarily.  At week 2 I contacted the infectious disease doctor. I was put on a waitlist and I got in at 4 weeks. We did inflammatory markers and she advised I not get the second dose. She said I have a profile of a hypersensitive immune system. I still have pain in my fingers and toes which comes and goes. I have not received the second dose. I had testing done throughout 2020 but none were positive. I believe I had COVID in February 2020. The antibodies were still present in January 2021.  I was also on an anti inflammatory diet.
Was given FLUARIX vaccine on 02/06/13 and had tenderness at site after injection. On 02/07/13 woke up with redness over injection site, area was tender, and red. No other symptoms. Was seen in clinic and evaluated. Was told to use ice packs on area. Call if symptoms worsen. Used Naproxen or Ibuprofen. The patient is a 29 year old female, here c/o possible reaction to flu vaccine. Injection site is red, hot, swollen and tender. This was noticed this morning. Has used an ice pack on the area. As above, patient had some tenderness at the injection site yesterday. This morning she noticed a red spot overlying it. It seems stable and is not worsening. No fevers, chills, shortness of breath, chest pain, nausea, vomiting, dizziness. The site is slightly itchy. She has had influenza vaccine in the past without any complications.
Information has been received from a physician concerning a 10 year old female with no past medical history, who on 12-OCT-2006 was vaccinated with a second dose of Varivax. There was no concomitant medication. On 15-OCT-2006 (also reported as 25-OCT-2006) the patient developed a desquamating rash in a "saddle-like" distribution in her inguinal/vaginal area which worsened over time. The number of lesions was unknown and at the time of the report the rash was resolving in this area after treatment with CALAMINE LOTION. Subsequently the patient developed new vesicles on the shoulder in an approximately 2X4 region, with 5 "tiny" vesicles, raised, papular, and erythematous. Unspecified medical attention was sought. The patient was otherwise well and without a fever. No other symptoms were reported. There was no product quality complaint involved. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified patients of unknown age and gender. No pertinent medical history, drug reactions/allergies and concomitant medications were reported. On an unspecified dates between September 2016 to October 2016, the unspecified patients were vaccinated with improperly stored doses of  PROQUAD (lot # M021731 and expiry date 29-OCT-2017) (lot # M031941 and expiry date 27-DEC-2017) (dosing regimen unknown) for prophylaxis. On an unspecified dates between September 2016 to October 2016, PROQUAD with lot number M021731 was exposed to temperature excursion of 6.7 Fahrenheit for 2 hours and 3 minutes, 18.7F for 3 hours and 39 minutes, 11.9 F for 2 hours and 37 minutes, 10.3F for 1 hour and 22 minutes, 9.5F for 3 hours and 32 minutes, 9.4F for 2 hours and 53 minutes, 8.8F for 56 minutes, 9.7F for 4 hours and 42 minutes and with lot number M031941 was exposed to 10.3 F for 1 hour and 22 minutes, 9.5F for 3 hours and 32 minutes , 9.4F for 2 hours and 53 minutes, 8.8 F for 56 minutes and 9.7 F for 4 hours and 42 minutes. No Previous temperature excursion were reported. The call was due to digital data logger. No symptoms were reported. No product quality complaint was filed. Information was received on 03-NOV-2016, lot number M031941(rHA) with expiry date 27-DEC-2017 was verified to be a valid lot number for PROQUAD. Information was received on 20-DEC-2016. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested. Sender's Comments: US-009507513-1610USA010372: MERCK 1610USA015091:Mfr number.
Patient presented to the ED on 5/5 after being sent by his PCP after an ultrasound in the office showed a DVT along with patient's complaint of shortness of breath. Patient denied history of DVT/PE. In the ED, CTA-PE showed bilateral pulmonary embolic disease and Ultrasound confirmed acute right lower extremity DVT. Patient was started on a heparin drip and then switched to enoxaparin 1 mg/kg every 12 hours per pulmonary. Hematology/Oncology was consulted and determined that acute bilateral PE likely provoked by recent vaccination with the second dose of the Pfizer vaccine. Patient was switched to rivaroxaban 20 mg daily prior to discharge for planned duration of 3 months.
Right arm round, red, warm area approx the size of a tennis ball. Shot given 5/27/03 - RTC on 5/29/03 - MD recommended Benadryl, Motrin and cold compresses.
This case was reported by a nurse via other and described the occurrence of anaphylactic reaction in a patient who received DTPA vaccine. On an unknown date, the patient received DTPA vaccine at an unknown dose. On an unknown date, an unknown time after receiving DTPA vaccine, the patient experienced anaphylactic reaction (serious criteria GSK medically significant and life threatening). On an unknown date, the outcome of the anaphylactic reaction was unknown. It was unknown if the reporter considered the anaphylactic reaction to be related to DTPA vaccine. Additional details were provided as follows: The nurse reported that a patient had an anaphylactic reaction after receiving DTPA vaccine. This case was not reported to the FDA. No further information was provided.
I went to the DR April 28th 2021 and she prescribed medication for eardrops, it still lingered so I went to urgent care twice. I had two different kinds of penicillin and took ear drops as well. I went to urgent care about two weeks ago in mid June 2021. I have an appointment on July 12th to see an ENT as well.